Glial fibrillary acidic protein is reduced in cerebellum of subjects with major depression, but not schizophrenia
Open accessThe DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Abstract
Glial fibrillary acidic protein (GFAP) is a major protein of astrocyte intermediate filaments and a specific marker for astrocytes. Alterations in levels of GFAP may reflect pathological regulation of neuronal function and survival as well as abnormal synaptogenesis and neurotransmission. We employed quantitative gel electrophoresis and Western blotting to measure levels of GFAP in cerebella of 60 subjects divided equally among schizophrenia, bipolar disorder, major depression, and normal controls. GFAP levels were reduced by 32%, 17% and 14.5% in depressed, bipolar, and schizophrenic cerebella, respectively, versus controls. Only the depressed value was significantly different (p=0.015 Post-hoc Bonferroni test). Measurement of beta-actin levels showed no differences between the various groups. No significant effects of confounding variables were found. This is the first demonstration of GFAP reductions in cerebellum of subjects with mood disorders and schizophrenia, thereby adding to the reports of reductions in GFAP/glial cell counts in other brain regions of subjects with major depression, thus suggesting a downregulation of glial function in this disorder.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Glial reduction in the subgenual prefrontal cortex in mood disorders
Öngür, D., Drevets, W. C., & Price, J. L. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.22.13290 · Cited by 1,525 · cited 4×
“Several previous studies using various methodologies showed glial dysfunction in all three disorders (Bowley et al., 2002; Rajkowska et al., 2002; Cotter et al., 2001; Miguel-Hidalgo et al., 2000; Rajkowska et al., 1999; Webster et al., 2001; Johnston-Wilson et al., 2000; Ongur et al., 1998).”
BackgroundResultInfluentialRajkowska, G., Miguel-Hidalgo, J. J., Wei, J., Dilley, G., Pittman, S. D., Meltzer, H. Y., Overholser, J. C., Roth, B. L., & Stockmeier, C. A. (1999) · Biological Psychiatry · doi:10.1016/s0006-3223(99)00041-4 · Cited by 1,477 · cited 4×
“Several previous studies using various methodologies showed glial dysfunction in all three disorders (Bowley et al., 2002; Rajkowska et al., 2002; Cotter et al., 2001; Miguel-Hidalgo et al., 2000; Rajkowska et al., 1999; Webster et al., 2001; Johnston-Wilson et al., 2000; Ongur et al., 1998).”
BackgroundInfluentialCotter, D., Mackay, D., Landau, S., Kerwin, R., & Everall, I. (2001) · Archives of General Psychiatry · doi:10.1001/archpsyc.58.6.545 · Cited by 766
Webster, M. J., Knable, M. B., Johnston-Wilson, N., Nagata, K., Inagaki, M., & Yolken, R. H. (2001) · Brain, Behavior, and Immunity · doi:10.1006/brbi.2001.0646 · Cited by 179 · cited 5×
“Several previous studies using various methodologies showed glial dysfunction in all three disorders (Bowley et al., 2002; Rajkowska et al., 2002; Cotter et al., 2001; Miguel-Hidalgo et al., 2000; Rajkowska et al., 1999; Webster et al., 2001; Johnston-Wilson et al., 2000; Ongur et al., 1998).”
BackgroundInfluential
Cited by
The stressed synapse: the impact of stress and glucocorticoids on glutamate transmission
Popoli, M., Yan, Z., McEwen, B. S., & Sanacora, G. (2012) · Nature Reviews Neuroscience · doi:10.1038/nrn3138 · Cited by 1,393
Towards a glutamate hypothesis of depression
Sanacora, G., Treccani, G., & Popoli, M. (2012) · Neuropharmacology · doi:10.1016/j.neuropharm.2011.07.036 · Cited by 1,036
The immune-mediated alteration of serotonin and glutamate: towards an integrated view of depression
Müller, N., & Schwarz, M. J. (2007) · Molecular Psychiatry · doi:10.1038/sj.mp.4002006 · Cited by 670
Enache, D., Pariante, C. M., & Mondelli, V. (2019) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2019.06.015 · Cited by 615
“, 2017), lateral cerebellum (Fatemi et al., 2004), and white matter in ventral prefrontal cortex (Rajkowska et al.”
BackgroundAstrocyte Pathology in Major Depressive Disorder: Insights from Human Postmortem Brain Tissue
Rajkowska, G., & Stockmeier, C. (2013) · Current Drug Targets · doi:10.2174/13894501113149990156 · Cited by 603
“Finally, significant decreases in GFAP protein expression and GFAP-IR astrocyte density were noted in the cerebellum [52] and amygdala [53] in MDD.”
Background
Metadata
- Authors
- Fatemi, S. H., Laurence, J. A., Araghi-Niknam, M., Stary, J. M., Schulz, S. C., Lee, S., & Gottesman, I. I.
- Venue
- Schizophrenia Research
- Publisher
- Elsevier BV
- Published
- 2004-08
- Volume
- 69
- Issue
- 2-3
- Pages
- 317-323
- ISSN
- 0920-9964 (ISSN-L)
- OpenAlex
- W2065912485
- Cited by
- 141
- References
- 4
- FWCI
- 2.00
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Glial fibrillary acidic protein is reduced in cerebellum of subjects with major depression, but not schizophrenia. https://app.cochat.ai/papers/10.1016/j.schres.2003.08.014
- The paper
- Fatemi, S. H., Laurence, J. A., Araghi-Niknam, M., Stary, J. M., Schulz, S. C., Lee, S., & Gottesman, I. I. (2004). Glial fibrillary acidic protein is reduced in cerebellum of subjects with major depression, but not schizophrenia. Schizophrenia Research. https://doi.org/10.1016/j.schres.2003.08.014
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.